But, and it’s a big but, we know that these drugs [biologic medications] don’t work in at least a third of patients with severe disease. It’s little consolation to those people to hear about the fantastic success of biologic therapies on others when they are still wracked with joint pain, struggling with fatigue, and unable to work.
Recognition that there remains a considerable unmet need was the driving force behind our decision to launch a new £2.5m rheumatoid arthritis research centre, looking into the causes (pathogenesis) of the disease.
Excellent article on Huffington Post UK about the severity of Rheumatoid Arthritis and how though we have made some strides, we still have a lot of work to do. Sounds like this new research center will be an amazing step forward!